These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

462 related items for PubMed ID: 15467734

  • 1. Epigenetic inactivation of class II transactivator (CIITA) is associated with the absence of interferon-gamma-induced HLA-DR expression in colorectal and gastric cancer cells.
    Satoh A, Toyota M, Ikeda H, Morimoto Y, Akino K, Mita H, Suzuki H, Sasaki Y, Kanaseki T, Takamura Y, Soejima H, Urano T, Yanagihara K, Endo T, Hinoda Y, Fujita M, Hosokawa M, Sato N, Tokino T, Imai K.
    Oncogene; 2004 Nov 25; 23(55):8876-86. PubMed ID: 15467734
    [Abstract] [Full Text] [Related]

  • 2. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M, Song Z, Gorga JC, Ksander B, Ono SJ.
    Invest Ophthalmol Vis Sci; 2004 Sep 25; 45(9):3185-95. PubMed ID: 15326139
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
    Meissner M, Whiteside TL, van Kuik-Romein P, Valesky EM, van den Elsen PJ, Kaufmann R, Seliger B.
    Br J Dermatol; 2008 May 25; 158(5):930-40. PubMed ID: 18284388
    [Abstract] [Full Text] [Related]

  • 5. Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer.
    Yazawa T, Kamma H, Fujiwara M, Matsui M, Horiguchi H, Satoh H, Fujimoto M, Yokoyama K, Ogata T.
    J Pathol; 1999 Jan 25; 187(2):191-9. PubMed ID: 10365094
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Different levels of control prevent interferon-gamma-inducible HLA-class II expression in human neuroblastoma cells.
    Croce M, De Ambrosis A, Corrias MV, Pistoia V, Occhino M, Meazza R, Giron-Michel J, Azzarone B, Accolla RS, Ferrini S.
    Oncogene; 2003 Oct 30; 22(49):7848-57. PubMed ID: 14586411
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Class II transactivator promoter activity is suppressed through regulation by a trophoblast noncoding RNA.
    Geirsson A, Paliwal I, Lynch RJ, Bothwell AL, Hammond GL.
    Transplantation; 2003 Jul 27; 76(2):387-94. PubMed ID: 12883198
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Alterations in CIITA constitute a common mechanism accounting for downregulation of MHC class II expression in diffuse large B-cell lymphoma (DLBCL).
    Cycon KA, Rimsza LM, Murphy SP.
    Exp Hematol; 2009 Feb 27; 37(2):184-194. PubMed ID: 19081173
    [Abstract] [Full Text] [Related]

  • 15. Prolonged MHC class II expression and CIITA transcription in human keratinocytes.
    Takagi A, Nishiyama C, Kanada S, Niwa Y, Fukuyama K, Ikeda S, Okumura K, Ogawa H.
    Biochem Biophys Res Commun; 2006 Aug 25; 347(2):388-93. PubMed ID: 16836979
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Detection of aberrant transcription of major histocompatibility complex class II antigen presentation genes in chronic lymphocytic leukaemia identifies HLA-DOA mRNA as a prognostic factor for survival.
    Souwer Y, Chamuleau ME, van de Loosdrecht AA, Tolosa E, Jorritsma T, Muris JJ, Dinnissen-van Poppel MJ, Snel SN, van de Corput L, Ossenkoppele GJ, Meijer CJ, Neefjes JJ, Marieke van Ham S.
    Br J Haematol; 2009 May 25; 145(3):334-43. PubMed ID: 19245431
    [Abstract] [Full Text] [Related]

  • 18. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM, Loftus EV, Sandborn WJ, Bryant SC, Smyrk TC.
    Gut; 2009 Sep 25; 58(9):1226-33. PubMed ID: 19251712
    [Abstract] [Full Text] [Related]

  • 19. MHC class II antigen presentation pathway in murine tumours: tumour evasion from immunosurveillance?
    Walter W, Lingnau K, Schmitt E, Loos M, Maeurer MJ.
    Br J Cancer; 2000 Nov 25; 83(9):1192-201. PubMed ID: 11027433
    [Abstract] [Full Text] [Related]

  • 20. Identification of distinct regions of 5' flanking DNA that mediate constitutive, IFN-gamma, STAT1, and TGF-beta-regulated expression of the class II transactivator gene.
    Piskurich JF, Wang Y, Linhoff MW, White LC, Ting JP.
    J Immunol; 1998 Jan 01; 160(1):233-40. PubMed ID: 9551976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.